During the past decade, Dallas Nephrology Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dallas Nephrology Associates" #1 sponsor was "Abbott" with 1 trials, followed by "Chiesi Farmaceutici S.p.A." with 1 trials sponsored, "Genzyme, a Sanofi Company" with 1 trials sponsored, "George Washington University" with 1 trials sponsored and "VentureMed Group Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dallas Nephrology Associates" #1 collaborator was "Chiesi USA, Inc." with 1 trials as a collaborator, "Coalition for Supportive Care of Kidney Patients" with 1 trials as a collaborator, "Gordon and Betty Moore Foundation" with 1 trials as a collaborator, "Stanford University" with 1 trials as a collaborator and "West Virginia University Research Corporation" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Dallas Nephrology Associates" are "Arteriovenous Fistula Stenosis" (1 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Disease Requiring Chronic Dialysis" (1 trials), "Chronic Kidney Diseases" (1 trials) and "End Stage Renal Disease" (1 trials). Many other conditions were trialed in "Dallas Nephrology Associates" in a lesser frequency.

Most popular intervention types in "Dallas Nephrology Associates" are "Drug" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Angioplasty" (1 trials), "Calcium-based phosphate binder" (1 trials), "FLEX Vessel Prep System" (1 trials), "IHI Breakthrough Collaborative Model" (1 trials) and "Pegunigalsidase Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dallas Nephrology Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Dallas Nephrology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Dallas Nephrology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dallas Nephrology Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".

Dallas Nephrology Associates has several departments that took part in Clinical trials: "Dallas Nephrology Associates" - 3 trials